利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

23 条记录 (耗时 0.017 秒)

    Device for packing pressure-sensitive adhesive substrate sections and the use thereof
    5.
    发明授权
    Device for packing pressure-sensitive adhesive substrate sections and the use thereof 有权
    用于包装压敏粘合剂基底部分的装置及其用途

    公开(公告)号：US06622865B1

    公开(公告)日：2003-09-23

    申请号：US09889132

    申请日：2001-08-01

    申请人： Frank Theobald

    发明人： Frank Theobald

    IPC分类号： B65D5700

    CPC分类号： B65D75/54 ,  A61F15/001

    摘要： An apparatus provides for increasing storage stability of substrate portion which is provided with a self-adhesive layer covered by a carrier layer and which and are packed in bags. The adhesive layer is protected by the carrier layer which projects beyond the self-adhesive layer, at least in some areas The adhesive layer is protected from adhesive bonding with packaging material of the bag in that in projecting regions, on a side of the carrier layer assigned to the substrate portion, there are arranged elevations, fixed to the side-or shaped out from it, as spacers with respect to the bag, and, in addition to the elevations on that side of the carrier layer which is assigned to the substrate portion, elevations designed as spacers are arranged on an opposite side of the carrier layer.

    摘要翻译： 一种装置提供了提供具有由载体层覆盖并且被包装在袋中的自粘层的基底部分的储存稳定性。 至少在一些区域中，粘合剂层被突出超过自粘层的载体层保护，粘合剂层被保护而不与袋的包装材料粘合，即在突出区域中，在载体层的一侧 分配给基板部分的布置有相对于袋固定到侧面或成形的高度作为间隔件，并且除了分配给基板的载体层的该侧上的高度之外 部分，设计为间隔物的立面布置在载体层的相对侧上。

    Type-2 Diabetes Combination Wafer
    7.
    发明申请
    Type-2 Diabetes Combination Wafer 审中-公开
    2型糖尿病组合晶片

    公开(公告)号：US20090274732A1

    公开(公告)日：2009-11-05

    申请号：US12308242

    申请日：2007-06-04

    申请人： Hans-Rainer Hoffmann ,  Reto Brandli ,  Frank Theobald

    发明人： Hans-Rainer Hoffmann ,  Reto Brandli ,  Frank Theobald

    IPC分类号： A61K9/00 ,  A61K31/165 ,  A61P3/10

    CPC分类号： A61K45/06 ,  A61K9/0056 ,  A61K9/006 ,  A61K31/155 ,  A61K31/198 ,  A61K31/64 ,  A61K2300/00

    摘要： Rapidly disintegrating oral dosage forms for the application of active agent combinations for diabetes therapy. The dosage forms contain at least two active agents suitable for treating type-2 diabetes. The antidiabetic active agents are selected from the group comprising sulfonylureas, glitazones, glinides, biguanides, and absorption-delaying agents. The use of the active agent combination to produce an oral dosage form for the treatment of diabetes, a method for the therapeutic treatment of diabetes, and a method for the production of a sheet-like dosage form are also disclosed.

    摘要翻译： 用于糖尿病治疗的活性药物组合的快速崩解口服剂型。 剂型含有至少两种适用于治疗2型糖尿病的活性剂。 抗糖尿病活性剂选自磺酰脲类，格列酮，格列奈类，双胍类和吸收延缓剂。 还公开了使用活性剂组合产生用于治疗糖尿病的口服剂型，糖尿病治疗性治疗方法和片状剂型的制备方法。